Naproxen incorporated lipid emulsions. I. Formulation and stability studies

Journal of Clinical Pharmacy and Therapeutics

Volumn 23, Issue 1, 1998, Pages 57-65

  Nasirideen, S ^a   Kas H S ^a   Oner F ^a   Alpar, R ^a   Hincal, A A ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; EMULSIFYING AGENT; NAPROXEN; PHOSPHATIDYLCHOLINE; SOYBEAN OIL; SYNPERONIC PEF 127; UNCLASSIFIED DRUG;

ARTICLE; DRUG SOLUBILITY; DRUG STABILITY; PARTICLE SIZE; PH; TEMPERATURE; VISCOSITY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; EXCIPIENTS; FAT EMULSIONS, INTRAVENOUS; HUMANS; HYDROGEN-ION CONCENTRATION; NAPROXEN; PARENTERAL NUTRITION; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; SOYBEAN OIL; TEMPERATURE; VISCOSITY; VITAMIN E;

EID: 0031821458     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1998.00139.x     Document Type: Article

References (37)

1. Bakan DA, Longino MA, Weichert JP, Counsell RE. (1996) Physicochemical characterization of a synthetic lipid emulsion for hepatocyte-selective delivery of lipophilic compounds: application to polyiodinated triglycerides as contrast agents for computed tomography. Journal of Pharmaceutical Sciences, 85, 908-913.
2. Herman CJ, Groves MJ. (1992) Hydrolysis kinetics of phospholipids in thermally stressed intravenous lipid emulsions formulations. Journal of Pharmacy and Pharmacology, 44, 539-542.
3. Chanana DG, Sheth BB. (1993) Particle size reduction of emulsions by formulation design I: effect of polyhydroxyalcohols. Journal of Parenteral Science and Technology, 72, 130-134.
4. Diederichs JE, Mehnert W, Lucks JS, Müller RH. (1992) Microviscosity measurements for the optimization of liposomes and emulsion formulations. Proceedings of the 6th International Conference of Pharmaceutical Technology (APGI), 5, 138-147.
5. Westesen K, Wehler T. (1992) Physicochemical characterization of a model of intravenous oil-in-water emulsion. Journal of Pharmaceutical Sciences, 81, 777-786.
6. Venkataram S, Awni WM, Jordan K, Rahman YE. (1990) Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid. Journal of Pharmaceutical Sciences, 79, 216-219.
7. Singh M, Ravin JL. (1986) Parenteral emulsions as drug carrier systems. Journal of Parenteral Sciences and Technology, 40, 34-41.
8. Davis SS, Hadgraft J, Palin KJ. (1985) Medical and pharmaceutical applications of emulsions. In: Encyclopedia of Emulsion Technology, ed. Becher P, vol. 2, pp. 159-225. Marcel Dekker Inc, New York.
9. Prankerd RJ, Stella VJ. (1990) The use of oil-in-water emulsions as a vehicle for parenteral drug administration. Journal of Parenteral Science and Technology, 44, 139-149.
10. Chen T, Lausier JM, Rhodes CT. (1986) Possible strategies for the formulation of antineoplastic drugs. Drug Deivlopment and Industrial Pharmacy, 12, 1084-1089.
11. Benita S, Friedman D, Weinstock M. (1986) Pharmacological evaluation of an injectable prolonged release emulsion of physostigmine in rabbit. Journal of Pharmacy and Pharmacology, 88, 653-658.
12. Benita S, Friedman D, Weinstock M. (1986) Evaluation of the reversal of flunitrazepam intoxication by a controlled-release physostigmine emulsion. 4th International Conference of Pharmaceutic Technology (APGI), 320-328.
13. Mbela TKMN, Lugwig A, Landau I, Deharo E, Haemers A. (1994) Preparation, characterization and in vivo activity of mefloquine submicron emulsions. International Journal of Pharmaceutics, 110, 189-196.
14. Levy YM, Langerman L, Gottschalk-Sabag S, Benita S. (1989) Side effect evaluation of a new diazepam formulation: venous sequela reduction following intravenous injection of a diazepam emulsion in rabbits. Pharmaceutical Research, 6, 510-516.
15. Yanagawa A, Iwayama T, Saotome T, Shoji Y, Takano K, Oka H, Nakagawa T, Mizushima Y. (1989) Selective transfer of cyclosporin to thoracic lymphatic systems by the application of lipid microspheres. Journal of Microencapsulation, 6, 161-164.
16. 1 in a lipid emulsion by ultrafiltration. Pharmaceutical Research, 5, 482-187.
17. Priedman D, Benita S. (1987) A mathematical model for drug release from o/w emulsions: application to controlled release morphine emulsions. Drug Development and Industrial Pharmacy, 13, 2067-2085.
18. 1 is more effective when incorporated in lipid microspheres for the treatment of peripheral diseases in man. Journal of Pharmacy and Pharmacology, 35, 666-667.
19. Shoji Y, Mizushima Y, Yanagawa A, et al. (1986) Enhancement of anti-inflammatory effects of biphenylylacetic acid by its incorporation into lipid microspheres. Journal of Pharmacy and Pharmacology, 38, 118-121.
20. Mizushima Y, Wada Y, Eroh Y, Watanabe K. (1983) Anti-inflammatory effect of indomethacin ester incorporated in a lipid microsphere. Journal of Pharmacy and Pharmacology, 35, 398-399.
21. Hughes JA, MRCP MB, Sudell W. (1982) Haemolytic anaemia associated with naproxen. British Medical Journal, 284, 1054.
22. Javala S, Saarimaa H, Anttila M, Sundquist H. (1977) Naproxen concentration in serum synovial fluid and synovium. Scandinavian Journal of Rheumatism, 6, 155-157.
23. Zech R, Scherkl R, Hashem A, Prey HH. (1993) Plasma and tissue kinetics of phenylbutazone and naproxen in dogs. Archives of International Pharmacodynamics, 325, 113-128.
24. Anttila M, Haataja M, Kasanen A. (1980) Pharmacokinetics of naproxen in subjects with normal and impaired renal function. European Journal of Clinical Pharmacology, 18, 263-268.
25. Erden N, Celebi N. (1989) Naproxen. FABAD-Journnl of Pharmaceutical Sciences, 14, 125-133.
26. Winer BJ. (1971) Statistical Principles in Experimental Design. 19 + 1, pp. 559-567. McGraw-Hill Book Company, New York.
27. Reed KW, Yalkowsky SH. (1985) Lysis of human red blood cells in the presence of various cosolvents. Journal of Parenteral Sciences and Technology, 39, 64-67.
28. Davis SS. (1974) Pharmaceutical aspect of intravenous fat emulsions. Journal of Hospital Pharmacy, 32, 149-169.
29. Levy MY, Benita S. (1989) Design and characterization of a submicronized o/w emulsion of diazepam for parenteral use. International Journal of Pharmaceutics, 54, 103-112.
30. Washington C, Koosha F, Davis SS. (1993) Physicochemical properties of parenteral fat emulsions containing 20% triglyceride: Intralipid and Invelip. Journal of Clinical Pharmacy and Therapeutics, 18, 123-131.
31. Ishii F, Sasaki I, Ogata H. (1990) Effect of phospholipid emulsifiers on the physicochemical properties of intravenous fat emulsion and/or drug carrier emulsion. Journal of Pharmacy and Pharmacology, 42, 513-515.
32. Santos Magalhaes NS, Cave G, Seiller M, Benita S. (1991) The stability and in vitro release kinetics of clofibride emulsion. International Journal of Pharmaceutics, 76, 225-237.
33. Florence AT, Attwood D. (1988) Disperse systems. In: Physicochemical Principles of Pharmacy. 2nd edn, pp. 239-256. Macmillan Press Ltd, London.
34. Sherman P. (1968) Rheology of emulsions. In: Emulsion Science, ed. Sherman P. pp. 217-347. Academic Press, London.
35. Yalabik-Kas HS. (1985) Stability assessment of emulsion systems. S.T.P. PHARMA Sciences, 1, 978-984.
36. Yalin M, Öner F, Öner L, Hincal AA. (1997) Preparation and properties of a stable intravenous lorazepam emulsion. Journal of Clinical Pharmacy and Therapeutics, 22, 39-44.
37. Ishii F, Nagasaka Y, Ogata H. (1989) Interaction between erythrocytes from various animals and emulsions stabilized with various lecithins. Journals of Pharmaceutical Sciences, 78, 303-306.